New Hampshire HB1702 mandates that pharmacies and medical facilities post signs informing patients about the potential reversibility of mifepristone.

New Hampshire HB1702 requires medical facilities and pharmacies to post signs informing patients about the potential reversibility of mifepristone, a drug used in chemical abortions. The signs must be visible in patient admission areas, consultation rooms, and prescription medication areas. The bill also outlines enforcement measures, including criminal penalties for violations and civil actions for women who were not informed. The act aims to ensure that women seeking chemical abortions are aware of the possibility to reverse the effects of mifepristone if the second pill has not been taken.

New Hampshire HB1702 mandates that pharmacies and medical facilities post signs informing patients about the potential reversibility of mifepristone.

New Hampshire HB1702 requires medical facilities and pharmacies to post signs informing patients about the potential reversibility of mifepristone, a drug used in chemical abortions. The signs must be visible in patient admission areas, consultation rooms, and prescription medication areas. The bill also outlines enforcement measures, including criminal penalties for violations and civil actions for women who were not informed. The act aims to ensure that women seeking chemical abortions are aware of the possibility to reverse the effects of mifepristone if the second pill has not been taken.